INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic ...
Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...
The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food ...
Bridge to Lifetm Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
Nestled between three sparkling lakes, Albert Lea is a hidden gem for retirees keeping an eye on their bank accounts. The ...
A recent article from Mayo Clinic President and CEO Gianrico Farrugia, M.D., offers a compelling glimpse of what that future ...
ROCHESTER — Mayo Clinic performed 2,065 solid organ transplants in 2025, the most in a single year in the health system's ...
Ahead of HIMSS26, Mayo Clinic’s Ugur Sener and Taylor Galloway preview their talk on using digital tools and decentralized ...
York-based WellSpan has announced that its nationally recognized MyWellSpan patient portal and application has surpassed one ...
WellSpan tops 1 million users on patient portal MyWellSpan, enhancing patient access to scheduling, billing, and provider communication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results